PTGS2 and coronary artery disorder: Fifth, one could argue that CHD risk in fibromyalgia patients can be potentiated by chronic use of anti-depressants and painkillers, including non-steroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 inhibitors (coxibs), which have been suggested to enhance cardiovascular risk.